Literature DB >> 12117205

Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus.

H Mega1, W W Jiang, M Takagi.   

Abstract

OBJECTIVES: Oral lichen planus (OLP) is a common mucocutaneous disorder and might be associated to a possible pathogenic relationship with hepatitis C virus (HCV) infection or hypersensitivity to dental alloy. We examined the clinical and immunohistochemical features of OLP associated with HCV infection (OLP-HCV), oral lichenoid contact sensitivity reaction (OLCSR), and idiopathic oral lichen planus (iOLP). The immunohistochemical expressions of CD4, CD8, B cells, Class II major histocompatibility complex antigen (HLA-DR), S-100, HSP60, Proliferating cell nuclear antigen (PCNA) and Ki-67 were compared to study the pathogenic differences of the three OLP groups.
MATERIALS AND METHODS: Three groups of OLP patients, (I) OLP-HCV patients (n = 17), (2) OLCSR patients (n = 10) and (3) iOLP patients (n = 14) were retrieved from clinical records and tissues examined immunohistochemically by the avidin-biotin-complex technique.
RESULTS: The patients with OLP-HCV showed widespread lesions. The proportion of CD8+ cells was found to be significantly higher in the lamina propria of the OLP-HCV patients and a significantly lower proportion of CD8+ cells of the OLCSR patients was noticed in the epithelium or the connective tissue papillae than in the iOLP patients. There were no significant differences in either the number of CD4+ cells or B cells between the three OLP groups. No significant differences in the number of HLA-DR+ cells were found between the three OLP groups and some OLP-HCV patients showed a significant increase of S-100+ cells in the epithelium compared with iOLP patients. There were no significant differences in either the number of PCNA+ or Ki-67+ cells between the groups. The patients showed similar weak expressions of HSP60 in the three OLP groups.
CONCLUSION: The different distributions of the CD8+ cells that could have functionally different roles might be related to the distinct pathogenic mechanisms in the three OLP groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12117205     DOI: 10.1034/j.1601-0825.2001.00718.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  7 in total

1.  Cys-X-Cys ligand 9 might be an immunological factor in the pathogenesis of oral submucous fibrosis and its concomitant oral lichenoid lesion.

Authors:  Ning Li; Qiong Hu; Canhua Jiang; Feng Guo; Krishna Munnee; Xinchun Jian; Yanjia Hu; Zhangui Tang
Journal:  Clin Oral Investig       Date:  2012-07-21       Impact factor: 3.573

2.  Cutaneous manifestations of viral hepatitis.

Authors:  Ahmed Akhter; Adnan Said
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.663

3.  Comparative study of number and distribution of IgG cells in oral lichen planus and oral lichenoid lesions.

Authors:  Parichehr Ghalayani; Seyed Mohammed Razavi; Darab Gholami
Journal:  Dent Res J (Isfahan)       Date:  2009

4.  Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers.

Authors:  F-M Chung; Y-H Yang; C-H Chen; C-C Lin; T-Y Shieh
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

5.  Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis.

Authors:  Abdullah Seckin Ertugrul; Ugur Arslan; Recep Dursun; Sema Sezgin Hakki
Journal:  Int J Oral Sci       Date:  2013-06-07       Impact factor: 6.344

Review 6.  Oral lichen planus: a microbiologist point of view.

Authors:  Tomás G Villa; Ángeles Sánchez-Pérez; Carmen Sieiro
Journal:  Int Microbiol       Date:  2021-03-10       Impact factor: 2.479

Review 7.  Oral conditions associated with hepatitis C virus infection.

Authors:  Seyed-Moayed Alavian; Nastaran Mahboobi; Nima Mahboobi; Peter Karayiannis
Journal:  Saudi J Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.